Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia

NCT01556022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Ischemia

Interventions

DEVICE: ADRCs processed by the Celution System
DEVICE: Placebo Comparator: Lactated Ringer's and Subject's Blood

Sponsor

Cytori Therapeutics